Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
04/2010
04/20/2010CA2448356C N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands
04/15/2010WO2010042758A2 Oxazole-pyridazine-oxazole alpha-helix mimetic
04/15/2010WO2010042674A1 Pyrrolone melanin concentrating hormone receptor-1 antagonists
04/15/2010WO2010042473A1 Biaryl spiroaminooxazoline analogues as alpha2c adrenergic receptor modulators
04/15/2010WO2010041219A1 2-benzothiophenyl-and 2-naphthyl-0xaz0lidin0nes and their azaisostere analogues as antibacterial agents
04/15/2010WO2010041218A2 Oxazolidinyl antibiotics
04/15/2010WO2010041054A1 Pyridine and pyrimidine based compounds as wnt signaling pathway inhibitors for the treatment of cancer
04/15/2010WO2010040843A2 Dibenzocycloheptanone derivatives and pharmaceutical agents containing said compounds
04/15/2010WO2010040826A1 6-phenyl-pyrimidin-4-yl-(phenylamine or phenoxy) derivatives useful as modulators of nicotinic acetylcholine receptors
04/15/2010WO2010040663A1 Pyrrolidine n-benzyl derivatives
04/15/2010WO2010040274A1 Novel dopamine d3 receptor ligands, the preparation and use thereof
04/15/2010WO2009125434A3 Oxime derivatives, process for their preparation, pharmaceutical composition containing the same and medicinal use thereof
04/15/2010US20100094010 Chemical process
04/15/2010US20100093802 Ccr9 inhibitors and methods of use thereof
04/15/2010US20100093732 Acid Addition Salts, Hydrates and Polymorphs of 5-(2,4-Dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic Acid Ethylamide and Formulations Comprising These Forms
04/15/2010US20100093731 Modulators for amyloid beta
04/15/2010US20100093730 Novel compounds as calcium channel blockers
04/15/2010US20100093729 Substituted gamma lactams as therapeutic agents
04/15/2010US20100093728 Novel substituted bipyridine derivatives and their use as adenosine receptor ligands
04/15/2010US20100093727 Compounds and methods of use
04/15/2010US20100093726 Novel 4-amino-quinoline derivatives useful as anti-malaria drugs
04/15/2010US20100093724 Azaindazole Compounds As CCR1 Receptor Antagonists
04/15/2010US20100093723 HETEROCYCLYL AND CYCLOALKYL SUBSTITUTED THIENO[2,3 d]PYRIMIDINE AND THEIR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS
04/15/2010US20100093718 Compounds
04/15/2010US20100093709 Tricyclic delta opioid modulators
04/15/2010US20100093703 Substituted arylsulphonylglycines, the preparation thereof and the use thereof as pharmaceutical compositions
04/15/2010US20100093702 METHYLENE AMINES OF THIENO[2,3-d]PYRIMIDINE AND THEIR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS
04/15/2010US20100093696 2-amino pyrimidine compounds
04/15/2010US20100093695 Substituted N-Arylsulfonylheterocyclic Amines As Gamma-Secretase Inhibitors
04/15/2010US20100093694 Compounds for the Treatment of Hepatitis C
04/15/2010US20100093690 5-phenylthiazole derivatives and use as pi3 kinase inhibitors
04/15/2010US20100093689 Heteroaryl compounds as p2y1 receptor inhibitors
04/15/2010US20100093669 Methods for preparing oxazolidinones and compositions containing them
04/15/2010US20100093668 N,n'-2,4-dianilinopyrimidine derivatives, preparation thereof as drugs, pharmaceutical compositions essentially as ikk inhibitors
04/15/2010US20100092426 2-substituted benzimidazoles
04/15/2010US20100092385 Novel Heteroaryl Substituted Imidazo [1,2-A] Pyridine Derivatives
04/15/2010CA2739527A1 Pyridine and pyrimidine based compounds as wnt signaling pathway inhibitors for the treatment of cancer
04/15/2010CA2739342A1 Oxazolidinyl antibiotics
04/15/2010CA2738870A1 Pyrrolidine n-benzyl derivatives
04/15/2010CA2738775A1 2-benzothiophenyl-and 2-naphthyl-0xaz0lidin0nes and their azaisostere analogues as antibacterial agents
04/14/2010EP2174939A1 Pyranones useful as ATM inhibitors
04/14/2010EP2174936A1 PNA monomer and precursor
04/14/2010EP2173744A1 Substituted (oxazolidinon-5-yl-methyl) -2-thiophene-carboxamides and use thereof in the field of blood coagulation
04/14/2010EP2173743A2 Sodium channel inhibitors
04/14/2010EP2173742A1 Crystalline form of [3-(4,5-dihydro-3-isoxazolyl)-2-methyl-4-(methylsulfonyl)phenyl]-(5-hydroxy-1-methyl-1h-pyrazol-4-yl)methanone
04/14/2010EP2173728A2 Heterocyclic modulators of pkb
04/14/2010EP2173715A2 Use of piperidine derivatives as agonists of chemokine receptor activity
04/14/2010EP2173354A1 Quinoxaline derivatives as pi3 kinase inhibitors
04/14/2010EP2173174A1 Farnesoid x receptor agonists
04/14/2010EP1919869B1 Indole derivatives as ppar activators
04/14/2010EP1805170B1 Mif-inhibitors
04/14/2010EP1694410B1 Cyclopropane derivatives and pharmaceutical use thereof
04/14/2010EP1537078B1 Indoles having anti-diabetic activity
04/14/2010EP1400515B1 Cyclic diamine compound having five-membered cyclic group
04/14/2010CN1995036B Optical purity alpha-substituted 2-methyl-5-nitro imidazole-1-ethanol derivative
04/14/2010CN101693710A Method for preparing Zolmitriptan
04/14/2010CN101693709A Bicyclic amides as kinase inhibitors
04/14/2010CN101693697A Pyrizdazine derivatives and their use as therapeutic agents
04/14/2010CN101693695A Pyrimidine derivatives and methods of treatment related to the use thereof
04/13/2010US7696246 Useful in female hormone replacement therapy and as modulators of fertility; therapy of dysfunctional uterine bleeding, dysmenorrhea, endometriosis, leiomyomas (uterine fibroids), hot flashes, mood disorders, meningiomas, cancer; 6-(bis-2,2,2-Trifluoroethyl)amino-4-trifluoromethylcoumarin
04/13/2010US7696233 Method for controlling particular insect pests by applying anthranilamide compounds
04/13/2010US7696231 Therapy, prevention of metabolism disorders; insulin resistance; antidiabetic agents; hypoglycemic agents; anticholesterol agents; obesity; polycystic ovarian syndrome
04/13/2010US7696229 Compounds having 5-HT6 receptor affinity
04/13/2010US7696226 HIV protease inhibiting compounds
04/13/2010US7696221 Thienoisoquinoline-phenylsulfonamides and their use as ER-NFκB inhibitors
04/13/2010US7696217 N-(pyridin-2-ylmethyl)-4-methyl-3-oxo-4-aza-5 alpha -androst-1-en-17 beta -acetamide; enhancement of weakened muscle tone; osteoporosis, bone disorders; ; periodontal disease, frailty, aging skin, male hypogonadism, postmenopausal symptoms, inflammatory arthritis, cachexia, Alzheimer's disease
04/13/2010US7696216 Aryl-quinazoline/aryl-2-amino-phenyl methanone derivatives
04/13/2010US7696215 N-isoxazol-3-yl-4-methyl-3-[6-(4-methylpiperazin-1-yl)-4-oxoquinazolin-3(4H)-yl]benzamide; rheumatoid arthritis, asthma, chronic obstructive pulmonary disease, inflammatory bowel disease, multiple sclerosis, AIDS, septic shock, congestive heart failure, ischaemic heart disease or psoriasis
04/13/2010US7696214 Confining solid tumors; administering a tyrosine kinase inhibitor as antitumor agents; 4-(6-chloro-2,3-methylenedioxyanilino)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-tetrahydropyran-4-yloxyquinazoline
04/13/2010US7696203 3-amino-N-[4-(2-morpholin-4-yl-1-benzopyran-4-one)-dibenzofuran-1-yl]-propionamides ; anticancer, antitumor agents
04/13/2010US7696202 IL-12 modulatory compounds
04/13/2010US7696199 Pyrazole compounds effective and selective toward the sigma receptors, e.g., 4-{2-(1-(3,4-dichlorophenyl)-5-methyl-1H pyrazol-3-yloxy)ethyl}morpholine; treatment of pain, more preferably neuropathic pain or allodynia; psychosis; neurodenerative disorders; antiinflammatory and - arthritic agents; obesity
04/13/2010US7696198 Phosphodiesterase 4 inhibitors
04/13/2010US7696196 (R)-1-(3,4-dibromo-benzyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidine-1-carboxylate, for example; treatment of headaches, particularly migraine or cluster headaches
04/13/2010US7696195 Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
04/13/2010US7696193 Such as 6-(3-cyclobutyl-2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-yloxy)-N-methyl-nicotinamide; for treatment of neurological and psychiatric disorders
04/13/2010CA2436220C New mandelic acid derivatives and their use as thrombin inhibitors
04/13/2010CA2432303C Pyrazole compounds useful as protein kinase inhibitors
04/13/2010CA2422377C Pyrazole compounds useful as protein kinase inhibitors
04/13/2010CA2336807C Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them
04/13/2010CA2333731C Organometallic complex molecule and organic electroluminescent device using the same
04/13/2010CA2295678C Pyridine derivatives
04/08/2010WO2010039947A1 Novel compounds as calcium channel blockers
04/08/2010WO2010039647A2 Selective inhibitors of c-jun n-terminal kinases
04/08/2010WO2010039534A2 Viral and fungal inhibitors
04/08/2010WO2010039256A1 2-acylaminopropoanol-type glucosylceramide synthase inhibitors
04/08/2010WO2010039237A1 Compounds for inflammation and immune-related uses
04/08/2010WO2010038465A1 8-substituted isoquinoline derivative and use thereof
04/08/2010WO2010038081A2 Heterocyclic derivatives and methods of use thereof
04/08/2010WO2010037723A1 Compounds which have activity at m1 receptor and their uses in medicine
04/08/2010WO2010037225A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
04/08/2010WO2010037210A1 Viral polymerase inhibitors
04/08/2010WO2010005692A3 Insecticidal cyclic carbonyl amidines
04/08/2010WO2009120615A3 Substituted gamma lactams as therapeutic agents
04/08/2010US20100087651 New mandelic acid derivatives and their use as thrombin inhibitors
04/08/2010US20100087491 Polycyclic compounds
04/08/2010US20100087479 Compositions Useful as Inhibitors of Voltage-Gated Sodium Channels
04/08/2010US20100087461 Arylamide pyrimidone compounds
04/08/2010US20100087442 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
04/08/2010US20100087434 NK-1 and Serotonin Transporter Inhibitors